Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21...

Por Drakos, E, Singh, R R, Rassidakis, G Z, Schlette, E, Li, J, Claret, F X, Ford, R J, Vega, F, Medeiros, L J
Publicado em 2011

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.

Por Gorgoulis, V. G., Zacharatos, P. V., Manolis, E., Ikonomopoulos, J. A., Damalas, A., Lamprinopoulos, C., Rassidakis, G. Z., Zoumpourlis, V., Kotsinas, A., Rassidakis, A. N., Halazonetis, T. D., Kittas, C.
Publicado em 1998